secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001140361-25-000132
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics amends convertible debentures, reduces near-term payments, conversion price to $0.27
--------------------------------------------------------------------------------

- Amendment defers December 2024 redemption; monthly payments cut from $1M to $500k for Jan-Jul 2025, then rise to $1.375M from Aug 2025.
- Conversion price reduced from $2.00 to $0.27; $15M principal convertible into 55.6M shares; 45.6M unregistered.
- Company issued 5M shares as consideration; forbears from redemption notices until July 31, 2025.
- Company to file registration statement for resale of shares by Jan 7, 2025.
- Canaccord Genuity acted as exclusive financial advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036125000132/0001140361-25-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036125000132/ny20039922x1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer